Detalhe da pesquisa
1.
Real-world outcomes following third or subsequent lines of therapy: A Danish population-based study on 189 patients with relapsed/refractory large B-cell lymphomas.
Br J Haematol
; 204(3): 839-848, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38009548
2.
VEXAS syndrome as a cause of debilitating fatigue and intermittent fever.
Ugeskr Laeger
; 185(8)2023 02 20.
Artigo
em Da
| MEDLINE | ID: mdl-36892319
3.
Diet-Induced Abdominal Obesity, Metabolic Changes, and Atherosclerosis in Hypercholesterolemic Minipigs.
J Diabetes Res
; 2018: 6823193, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-29682581
4.
Treatment with a human recombinant monoclonal IgG antibody against oxidized LDL in atherosclerosis-prone pigs reduces cathepsin S in coronary lesions.
Int J Cardiol
; 215: 506-15, 2016 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27135822
5.
REPLY: Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing.
Int J Cardiol
; 229: 8, 2017 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28003044